Literature DB >> 1932183

A new method for faster blood clearance in radioimmuno-guided surgery.

G Paganelli1, M Stella, P De Nardi, P Magnani, F Zito, A G Siccardi, V Di Carlo, F Fazio.   

Abstract

A major inconvenience of intraoperative tumor detection with radiolabeled monoclonal antibody (MoAb) by means of a probe is the long interval needed between the injection of MoAb and surgery (at least 20 days). We describe a new method which entails injection of 125I-labeled biotinylated monoclonal antibodies and cold avidin in order to obtain a rapid blood clearance of the radiotracer. The first clinical application of this protocol has been carried out in a colon cancer patient operated on six days after the administration of 125I-labeled biotinylated MoAb and cold avidin, with an optimal tumor-to-normal tissue ratio and with 90% of the circulating radioactivity cleared in two days.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932183

Source DB:  PubMed          Journal:  J Nucl Biol Med        ISSN: 0368-3249


  4 in total

1.  Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.

Authors:  D Marshall; R B Pedley; J A Boden; R Boden; R H Begent
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

2.  Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.

Authors:  D Marshall; R B Pedley; J A Boden; R Boden; R G Melton; R H Begent
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

3.  Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.

Authors:  D Marshall; R B Pedley; R G Melton; J A Boden; R Boden; R H Begent
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

4.  Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody.

Authors:  H Kobayashi; H Sakahara; K Endo; M Hosono; Z S Yao; S Toyama; J Konishi
Journal:  Jpn J Cancer Res       Date:  1995-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.